CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 4.92: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.22%Below 5Y avg (2.32%)
Annual Rate
CNY 0.20Paid annual
Payout Ratio
55.1%Sustainable
Payback Period
45.2 yr
Last Ex-Dividend
Sep 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.70BCNY701.93M · vs all stocks (USD)
Trailing P/E
16.69xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.72BCNY256.08M · vs all stocks (USD)
Profit Margin
16.43%vs Medical Instruments & Supplies peers
Beta
0.1010xvs all stocks
52-Week Change
-4.05%vs all stocks
Market Capitalization
4.70BCNY701.93M · vs all stocks (USD)
Enterprise Value
4.50BCNY670.97M · vs all stocks (USD)
Trailing P/E
16.69xvs Medical Instruments & Supplies peers
Forward P/E
18.02xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.74xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.15xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.62xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
10.35xvs Medical Instruments & Supplies peers
Gross Margin
35.62%vs Medical Instruments & Supplies peers
Profit Margin
16.43%vs Medical Instruments & Supplies peers
Operating Margin
16.23%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
8.23%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
20.54%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.72BCNY256.08M · vs all stocks (USD)
Revenue per Share (TTM)
3.32CNYUpdated Sep 20, 2026Quarterly Revenue Growth
6.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
621.99MCNY92.81M · vs all stocks (USD)
EBITDA (TTM)
348.10MCNY51.94M · vs all stocks (USD)
Net Income (TTM)
281.94MCNY42.07M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
3.90%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
426.90MCNY63.70M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
94.47MCNY14.10M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2000CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
2.22%vs all stocks
5-Year Average Dividend Yield
2.32%vs all stocks
Payout Ratio
55.10%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
95.27MCNYFY2025 · Dec 31, 2025Revenue
1.64BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.05BCNYFY2025 · Dec 31, 2025Gross Profit
590.86MCNYFY2025 · Dec 31, 2025Operating Income
326.75MCNY48.76M · vs all stocks (USD)
Pre-tax Income
324.24MCNYFY2025 · Dec 31, 2025Income Tax Expense
33.97MCNYFY2025 · Dec 31, 2025Net Income
290.27MCNYFY2025 · Dec 31, 2025EBIT
326.06MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
458.89MCNYFY2025 · Dec 31, 2025Research & Development
75.28MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
69.31MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.90MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.16MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.82MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5117CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5117CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
517.76MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
517.76MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
290.27MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-25.33MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
256.22MCNYFY2025 · Dec 31, 2025Free Cash Flow
15.01MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
418.16MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
290.27MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.94MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-19.47MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-16.51MCNYFY2025 · Dec 31, 2025Capital Expenditures
-241.21MCNYFY2025 · Dec 31, 2025Purchase of Investments
-881.50MCNYFY2025 · Dec 31, 2025Sale of Investments
967.35MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-155.36MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
81.34MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-69.40MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-163.29MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.28MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-152.63MCNYFY2025 · Dec 31, 2025Shares Outstanding
522.08MSharesUpdated Sep 20, 2026Float Shares
296.23MSharesUpdated Sep 20, 2026% Held by Insiders
50.27%vs all stocks
% Held by Institutions
2.86%vs all stocks
Total Cash (MRQ)
524.47MCNY78.26M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.00CNYUpdated Sep 20, 2026Total Debt (MRQ)
244.64MCNY36.51M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1561xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.42xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
2.86CNYUpdated Sep 20, 2026Total Assets
2.43BCNY362.44M · vs all stocks (USD)
Total Current Assets
925.20MCNYFY2025 · Dec 31, 2025Total Liabilities
875.32MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.50BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
265.82MCNYFY2025 · Dec 31, 2025Total Current Liabilities
609.51MCNYFY2025 · Dec 31, 2025Cash
418.16MCNYFY2025 · Dec 31, 2025Cash Equivalents
13.31MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
431.47MCNYFY2025 · Dec 31, 2025Other Short-term Investments
157.45MCNYFY2025 · Dec 31, 2025Accounts Receivable
76.65MCNYFY2025 · Dec 31, 2025Inventory
199.97MCNYFY2025 · Dec 31, 2025Accounts Payable
394.12MCNYFY2025 · Dec 31, 2025Short-term Debt
49.34MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.92MCNYFY2025 · Dec 31, 2025Long-term Debt
180.69MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
461.46KCNYFY2025 · Dec 31, 2025Common Stock (Book)
522.08MCNYFY2025 · Dec 31, 2025Retained Earnings
735.36MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.55BCNY231.82M · vs all stocks (USD)
Treasury Stock
13.15MCNYFY2025 · Dec 31, 202552-Week Low
8.60CNYUpdated Sep 20, 202652-Week High
10.78CNYUpdated Sep 20, 202652-Week Change
-4.05%vs all stocks
Beta
0.1010xvs all stocks
50-Day MA
9.51CNYUpdated Sep 20, 2026200-Day MA
9.49CNYUpdated Sep 20, 2026Avg 10-Day Volume
4.91MSharesUpdated Sep 20, 2026Avg 30-Day Volume
11.07MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.5400CNYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.92: safe zoneNotable
Altman Z-Score: 4.92
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Mitsuboshi Belting Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Mining Machinery Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Cem Zeytin A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Huali Industries Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chongqing Sulian Plastic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ruitai Materials Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
American Woodmark Corporation
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Shandong Fengyuan Chemical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou Sunmun Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Yangzhou Seashine New Materials Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Fiem Industries Ltd.
1 interpretationIndustry-Benchmarked Return on Capital Elevated
Zhejiang Wellsun Intelligent Technology Co., Ltd.
1 interpretationIndustry-Benchmarked Return on Capital Elevated
GEA Group AG
1 interpretationIndustry-Benchmarked Return on Capital Elevated